NCT01862835View on ClinicalTrials.gov

Impact of Estradiol Addback

PHASE1CompletedINTERVENTIONAL

Enrollment

43

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

December 30, 2018

Conditions

Normal Healthy Volunteers

Interventions

DRUG

Degarelix

DRUG

Testosterone

DRUG

Anastrozole

DRUG

Estrogen patch

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT01862835 - Impact of Estradiol Addback | Biotech Hunter | Biotech Hunter